Published February 26, 2007, 12:48 PM CST
Abbott Laboratories confirmed today that the company is eliminating about 200 jobs in its drug discovery business as part of a recently completed reorganization.
The jobs, which are part of Abbott's global pharmaceutical business, are primarily located in Lake County where the company employs 14,000 of its global workforce of about 65,000. The jobs being cut are primarily research jobs, including scientists and other researchers.
"They (the job cuts) are in early discovery, metabolic research such as obesity and treatments for diabetes – that kind of early pharmaceutical research," said Jonathon Hamilton, an Abbott spokesman. "This is, early, early clinical compounds that we are stopping research on. It just effects that early research."
Abbott said the job cuts are the result of a recently completed reorganization of its drug discovery business. The company's previously stated drug discovery focus is on immunology, infectious diseases, cancer, neuroscience and pain management, which the company says are its primary areas of drug research and discovery.
http://www.chicagotribune.com/business/chi-070226abbott,0,1737136.story?coll=chi-business-hed